Literature DB >> 9930750

GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice.

M Shimoji1, K Hirayama, K Hyland, G Kapatos.   

Abstract

The hph-1 mouse is characterized by low levels of GTP cyclohydrolase I (GTPCH) and tetrahydrobiopterin. A quantitative double-label in situ hybridization technique was used to examine CNS GTPCH mRNA expression within serotonin, dopamine, and norepinephrine neurons of male and female wild-type and hph-1 mice. In wild-type male and female animals the highest levels of GTPCH mRNA expression were observed within serotonin neurons, followed by norepinephrine and then dopamine neurons. Wild-type female animals were found to express lower levels of GTPCH mRNA in each cell type when compared with levels seen in wild-type males. GTPCH mRNA abundance in all three cell types was lower in hph-1 male than in wild-type male mice, with the greatest reduction in serotonin neurons. GTPCH mRNA levels were also lower in hph-1 female than in wild-type female mice, again with the greatest reduction occurring in serotonin neurons. Comparison of hph-1 male and hph-1 female mice revealed that the sex-linked difference in GTPCH mRNA expression observed in wild-type neurons was only present within female dopamine neurons. Overall, these results indicate that not only are basal levels of GTPCH mRNA expression heterogeneous across wild-type murine monoamine cell types but that gene expression is also modified in a sex-linked and cell-specific fashion by the hph-1 gene locus. The hph-1 mutation does not lie within the GTPCH mRNA coding region. The 5' flanking region of the GTPCH gene was cloned and sequenced and shown to be identical for both wild-type and hph-1 genomic DNA. Transient transfection assays performed in PC12 cells demonstrated that this 5' flanking region was sufficient to initiate transcription of a luciferase reporter gene. Although the hph-1 mutation does not lie within the 5' flanking region of the GTPCH gene, this region of the gene can function as a core promoter and is thus crucial to the control of GTPCH gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9930750     DOI: 10.1046/j.1471-4159.1999.0720757.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

2.  GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

Authors:  Hiroyo Yoshino; Kenya Nishioka; Yuanzhe Li; Yutaka Oji; Genko Oyama; Taku Hatano; Yutaka Machida; Yasushi Shimo; Arisa Hayashida; Aya Ikeda; Kaoru Mogushi; Yasuro Shibagaki; Ai Hosaka; Hiroshi Iwanaga; Junko Fujitake; Takekazu Ohi; Daigo Miyazaki; Yoshiki Sekijima; Mitsuaki Oki; Hirofumi Kusaka; Ken-Ichi Fujimoto; Yoshikazu Ugawa; Manabu Funayama; Nobutaka Hattori
Journal:  J Neurol       Date:  2018-06-14       Impact factor: 4.849

3.  Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.

Authors:  Gregory Oxenkrug
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

4.  Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cerebral microvessels of hph-1 mice.

Authors:  Anantha Vijay R Santhanam; Livius V d'Uscio; Leslie A Smith; Zvonimir S Katusic
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

5.  Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5.

Authors:  C Wider; S Melquist; M Hauf; A Solida; S A Cobb; J M Kachergus; J Gass; K D Coon; M Baker; A Cannon; D A Stephan; D F Schorderet; J Ghika; P R Burkhard; G Kapatos; M Hutton; M J Farrer; Z K Wszolek; F J G Vingerhoets
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

6.  GCH1 expression in human cerebellum from healthy individuals is not gender dependent.

Authors:  Christian Wider; Sarah Lincoln; Justus C Dachsel; Gregory Kapatos; Michael G Heckman; Nancy N Diehl; Spiridon Papapetropoulos; Deborah Mash; Alex Rajput; Ali H Rajput; Dennis W Dickson; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Neurosci Lett       Date:  2009-06-30       Impact factor: 3.046

7.  Protein kinase A-dependent recruitment of RNA polymerase II, C/EBP beta and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation.

Authors:  Gregory Kapatos; Prashanthi Vunnava; Yanning Wu
Journal:  J Neurochem       Date:  2007-03-29       Impact factor: 5.372

Review 8.  Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Authors:  Ruben J Boado
Journal:  Pharm Res       Date:  2007-06-08       Impact factor: 4.200

Review 9.  Nonmotor Symptoms in Dopa-Responsive Dystonia.

Authors:  Elena Antelmi; Maria Stamelou; Rocco Liguori; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2015-07-22

10.  Impaired behavioural pain responses in hph-1 mice with inherited deficiency in GTP cyclohydrolase 1 in models of inflammatory pain.

Authors:  Arafat Nasser; Ole J Bjerrum; Anne-Marie Heegaard; Anette T Møller; Majbritt Larsen; Louise S Dalbøge; Erik Dupont; Troels S Jensen; Lisbeth B Møller
Journal:  Mol Pain       Date:  2013-02-19       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.